Patents Assigned to Beijing Century Biocom Pharmaceutical Technology Co., Ltd.
  • Patent number: 8044093
    Abstract: A pharmaceutical composition of docetaxel comprising an effective amount of docetaxel, a polysorbate (TWEEN® compound) and a co-solvent, wherein the co-solvent is at least one member selected from the group consisting of glycerol and polyethylene glycol. The composition is an injectable solution or a freeze-dried powder for injection. The solubility of decetaxel is improved by adding a polysorbate and a co-solvent. Methods of preparation of the pharmaceutical composition are also disclosed.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: October 25, 2011
    Assignee: Beijing Century Biocom Pharmaceutical Technology Co., Ltd.
    Inventor: Shouzhu Hao
  • Publication number: 20090170810
    Abstract: A method for treating an ischemic cardiovascular or cerebrovascular disease comprising administrating to a patient in the need of such treatment a pharmaceutical composition comprising low molecular weight fucoidan.
    Type: Application
    Filed: March 4, 2009
    Publication date: July 2, 2009
    Applicant: Beijing Century Biocom Pharmaceutical Technology Co. Ltd.
    Inventor: Shouzhu HAO
  • Publication number: 20090170801
    Abstract: A method for treating an ischemic cardiovascular or cerebrovascular disease comprising administrating to a patient in the need of such treatment a pharmaceutical composition comprising fucoidan.
    Type: Application
    Filed: March 4, 2009
    Publication date: July 2, 2009
    Applicant: Beijing Century Biocom Pharmaceutical Technology Co. Ltd.
    Inventor: Shouzhu HAO
  • Publication number: 20080306137
    Abstract: A pharmaceutical composition of docetaxel comprising an effective amount of docetaxel, a polysorbate (TWEEN® compound) and a co-solvent, wherein the co-solvent is at least one member selected from the group consisting of glycerol and polyethylene glycol. The composition is an injectable solution or a freeze-dried powder for injection. The solubility of decetaxel is improved by adding a polysorbate and a co-solvent. Methods of preparation of the pharmaceutical composition are also disclosed.
    Type: Application
    Filed: August 20, 2008
    Publication date: December 11, 2008
    Applicant: BEIJING CENTURY BIOCOM PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventor: Shouzhu HAO